Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             156 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of large cell carcinoma of the lung arising from the inner surface of a pulmonary bulla and complicated by hematoma 1996
14 1 p. 163-
1 p.
artikel
2 A case of postoperative hyponatremia caused by Sheehan syndrome associated with lung carcinoma 1996
14 1 p. 158-
1 p.
artikel
3 Accelerated induction therapy and resection for poor prognostic stage III non-small cell lung cancer 1996
14 1 p. 177-178
2 p.
artikel
4 Acquired TGFβ 1 sensitivity and TGFβ 1 expression in cell lines established from a single small cell lung cancer patient during clinical progression Nørgaard, Peter
1996
14 1 p. 63-73
11 p.
artikel
5 Adjuvant and neo-adjuvant chemotherapy in non-small cell carcinoma 1996
14 1 p. 175-
1 p.
artikel
6 Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma: A randomized trial of 267 patients 1996
14 1 p. 176-
1 p.
artikel
7 A hereditary genetic marker closely associated with microsatellite instability in lung cancer 1996
14 1 p. 153-
1 p.
artikel
8 Airway stents: Present and future 1996
14 1 p. 164-
1 p.
artikel
9 A long-term survivor of the squamous cell lung cancer with chest-wall invasion effectively treated by irradiation and hyperthermia 1996
14 1 p. 175-
1 p.
artikel
10 Altered expression of the p50 subunit of the NF-kappaB transcription factor complex in non-small cell lung carcinoma 1996
14 1 p. 153-
1 p.
artikel
11 Ambulatory low-toxicity chemotherapy in non-small-cell lung carcinoma by continuous 28-day infusion of alternating cisplatin and 5-fluorouracil 1996
14 1 p. 167-
1 p.
artikel
12 Anemia and changes in serum erythropoietin levels during chemotherapy for lung cancer 1996
14 1 p. 169-
1 p.
artikel
13 A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: A University of Colorado Cancer Center study 1996
14 1 p. 172-
1 p.
artikel
14 A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer 1996
14 1 p. 170-171
2 p.
artikel
15 A proposed new International TNM Staging System for malignant pleural mesothelioma from the International Mesothelioma Interest Group Rusch, Valerie W.
1996
14 1 p. 1-12
12 p.
artikel
16 A prospective randomised study in limited disease small cell carcinoma—doxorubicin and vincristine plus either cyclophosphamide or etoposide 1996
14 1 p. 167-
1 p.
artikel
17 Are bilobectomies acceptable procedures? 1996
14 1 p. 163-164
2 p.
artikel
18 A resected case of double primary lung cancers, each with coexistent metastasis in the same mediastinal lymph node 1996
14 1 p. 164-
1 p.
artikel
19 Association of body mass index and body fat distribution with risk of lung cancer in older women 1996
14 1 p. 152-
1 p.
artikel
20 Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation 1996
14 1 p. 151-
1 p.
artikel
21 Axillary lymph node metastases of bronchogenic carcinoma 1996
14 1 p. 162-163
2 p.
artikel
22 Binding capacities of two immunomodulatory lectins, carrier-immobilized glycoligands and steroid hormones in lung cancer and the concentration of nitrite/nitrate in pleural effusions Timoshenko, A.V.
1996
14 1 p. 75-84
10 p.
artikel
23 Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide 1996
14 1 p. 169-
1 p.
artikel
24 Bronchial artery infusion of chemotherapeutic agents plus external irradiation in the treatment of advanced lung cancer —A report of 37 cases 1996
14 1 p. 176-
1 p.
artikel
25 Bronchioloalveolar carcinoma 1996
14 1 p. 178-
1 p.
artikel
26 Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: A preliminary report 1996
14 1 p. 177-
1 p.
artikel
27 Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis 1996
14 1 p. 152-
1 p.
artikel
28 Changes of ventilatory and respiratory function of the lungs after pneumonectomy 1996
14 1 p. 165-166
2 p.
artikel
29 Characteristics of non-small cell lung cancer 3 cm or less in diameter 1996
14 1 p. 162-
1 p.
artikel
30 Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background 1996
14 1 p. 152-153
2 p.
artikel
31 Chemoradiation in advanced nonsmall cell lung cancer 1996
14 1 p. 175-
1 p.
artikel
32 Chemotherapy in non-small cell lung cancer 1996
14 1 p. 168-
1 p.
artikel
33 Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials 1996
14 1 p. 167-168
2 p.
artikel
34 Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma 1996
14 1 p. 158-159
2 p.
artikel
35 Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription 1996
14 1 p. 153-154
2 p.
artikel
36 Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA B non-small cell carcinoma of the lung 1996
14 1 p. 177-
1 p.
artikel
37 Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: A phase I and pharmacokinetic study 1996
14 1 p. 177-
1 p.
artikel
38 Cost analysis of hospital treatment—two chemotherapic regimens for non-surgical non-small cell lung cancer Vergnenègre, A
1996
14 1 p. 31-44
14 p.
artikel
39 Cost utility of chemotherapy and best supportive care in non-small cell lung cancer 1996
14 1 p. 179-
1 p.
artikel
40 Cytotoxicity of a novel indoloquinone EO9 in hypoxic nonsmall cell lung cancer cell lines 1996
14 1 p. 168-
1 p.
artikel
41 Detection of circulating cancer cells by RT-PCR in patients with resectable lung cancer 1996
14 1 p. 159-
1 p.
artikel
42 Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma 1996
14 1 p. 157-
1 p.
artikel
43 Diagnosing the indeterminate pulmonary nodule: percutaneous biopsy versus thoracoscopy 1996
14 1 p. 157-
1 p.
artikel
44 Dissemination in athymic nude mice of lacZ transfected small cell lung cancer cells identified by X-gal staining 1996
14 1 p. 153-
1 p.
artikel
45 Distribution of the different histologic types of bronchogenic carcinoma 1996
14 1 p. 155-
1 p.
artikel
46 Docetaxel in stage III and IV non-small cell lung cancer 1996
14 1 p. 166-
1 p.
artikel
47 Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer 1996
14 1 p. 171-
1 p.
artikel
48 Early alternating chemotheapy and radiotherapy schedule in limited disease stage small cell lung cancer 1996
14 1 p. 175-
1 p.
artikel
49 Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer Copley-Merriman, Catherine
1996
14 1 p. 45-61
17 p.
artikel
50 Editorial Board 1996
14 1 p. IFC-
1 p.
artikel
51 Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer Urban, Thierry
1996
14 1 p. 109-117
9 p.
artikel
52 Electron microscopic morphometry of the nucleus and its clinical significance in adenocarcinoma of the lung 1996
14 1 p. 155-156
2 p.
artikel
53 Endobronchial brachytherapy 1996
14 1 p. 174-
1 p.
artikel
54 Enlarged mediastinal nodes as markers of involvement by NSCLC 1996
14 1 p. 162-
1 p.
artikel
55 Establishment of human lung adenocarcinoma cisplatin-resistant cell line A549 DDP and the mechanism of it's drug resistance 1996
14 1 p. 169-170
2 p.
artikel
56 Etoposide administered orally in the treatment of lung cancer 1996
14 1 p. 170-
1 p.
artikel
57 Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18] fluoromisonidazole positron emission tomography 1996
14 1 p. 173-
1 p.
artikel
58 Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: A preliminary report 1996
14 1 p. 168-169
2 p.
artikel
59 Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer 1996
14 1 p. 159-
1 p.
artikel
60 Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium Zhou, J.
1996
14 1 p. 85-97
13 p.
artikel
61 Expression of α3β1 integrin receptor and its ligands in human lung tumors 1996
14 1 p. 156-
1 p.
artikel
62 Four-day paclitaxel infusion with cisplatin for patients with lung cancer 1996
14 1 p. 170-
1 p.
artikel
63 Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines 1996
14 1 p. 154-
1 p.
artikel
64 Gene therapy for lung cancer 1996
14 1 p. 179-
1 p.
artikel
65 Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis 1996
14 1 p. 150-
1 p.
artikel
66 Giant cell carcinoma of the lung 1996
14 1 p. 149-
1 p.
artikel
67 Good results of surgical treatment of elderly patients with stage I lung cancer 1996
14 1 p. 165-
1 p.
artikel
68 High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma 1996
14 1 p. 154-
1 p.
artikel
69 Higher lung cancer risk for younger African-Americans with the Pro Pro p53 genotype 1996
14 1 p. 151-
1 p.
artikel
70 Histogenesis of adenosquamous bronchogenic carcinoma 1996
14 1 p. 155-
1 p.
artikel
71 Human non-small cell lung cancer cells express a type 2 cytokine pattern 1996
14 1 p. 154-
1 p.
artikel
72 Hypofractionated irradiation for inoperable non-small cell lung cancer 1996
14 1 p. 174-
1 p.
artikel
73 IASLC calendar 1996
14 1 p. 147-148
2 p.
artikel
74 Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking 1996
14 1 p. 149-
1 p.
artikel
75 Imaging and staging of small-cell lung cancer: Is there a future role for octreotide scintigraphy? 1996
14 1 p. 158-
1 p.
artikel
76 Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma 1996
14 1 p. 164-
1 p.
artikel
77 Insulin like growth factor (IGF) and IGF binding proteins in growth hormone dysregulation and abnormal glucose tolerance in small cell lung cancer patients 1996
14 1 p. 159-160
2 p.
artikel
78 Intensive chemotherapy with autologous bone marrow transplantation for advanced lung cancer 1996
14 1 p. 169-
1 p.
artikel
79 Is there a role for chemotherapy of non-small cell lung cancer? 1996
14 1 p. 168-
1 p.
artikel
80 Long-term survival after removal of a single brain metastasis from lung carcinoma 1996
14 1 p. 160-161
2 p.
artikel
81 Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung 1996
14 1 p. 173-
1 p.
artikel
82 Lung cancer Sculier, J.-P.
1996
14 1 p. 145-146
2 p.
artikel
83 Lung cancer and mutations at the polymorphic NAT2 gene locus 1996
14 1 p. 154-155
2 p.
artikel
84 Management (chemotherapy/best supportive care) of advanced-stage non-small cell lung cancer 1996
14 1 p. 170-
1 p.
artikel
85 Measurement of serum pro-gastrin-releasing peptide as an indicator for monitoring therapeutic effects in patients with small cell lung carcinoma 1996
14 1 p. 162-
1 p.
artikel
86 Mediastinal staging of non-small-cell lung cancer: Computed tomography and cervical mediastinoscopy 1996
14 1 p. 157-
1 p.
artikel
87 Microvessel count predicts metastatic disease and survival in non-small cell lung cancer 1996
14 1 p. 158-
1 p.
artikel
88 Modality of failure following resection of stage I and stage II non-small cell lung cancer 1996
14 1 p. 164-165
2 p.
artikel
89 Molecular and biological factors in the prognosis of non-small cell lung cancer 1996
14 1 p. 161-
1 p.
artikel
90 Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer Pérol, M.
1996
14 1 p. 119-134
16 p.
artikel
91 N-acetylcysteine (NAC) and glutathione (GSH): Antioxidant and chemopreventive properties, with special reference to lung cancer 1996
14 1 p. 152-
1 p.
artikel
92 Nd YAG laser and brachytherapy in the treatment of lung cancer 1996
14 1 p. 178-
1 p.
artikel
93 New drugs in the treatment of non-small cell lung cancer 1996
14 1 p. 168-
1 p.
artikel
94 Occupational risk factors for lung cancer in Tianjin, China 1996
14 1 p. 153-
1 p.
artikel
95 Osteolytic bone lesions in a patient with idiopathic myelofibrosis and bronchial carcinoma 1996
14 1 p. 158-
1 p.
artikel
96 Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer 1996
14 1 p. 172-173
2 p.
artikel
97 Paclitaxel and ifosfamide: A multicenter phase I study in advanced non-small cell lung cancer 1996
14 1 p. 171-
1 p.
artikel
98 Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer 1996
14 1 p. 171-
1 p.
artikel
99 Paclitaxel by 24- or 1-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: The Fox Chase Cancer Center experience 1996
14 1 p. 172-
1 p.
artikel
100 Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC) 1996
14 1 p. 167-
1 p.
artikel
101 Paclitaxel 3-hour infusion given alone and combined with carboplatin: Preliminary results of dose-escalation trials 1996
14 1 p. 170-
1 p.
artikel
102 Paclitaxel plus carboplatin for advanced lung cancer: Preliminary results of a Vanderbilt university phase II trial-LUN-46 1996
14 1 p. 171-172
2 p.
artikel
103 p53 and disease progression in patients with non-small cell lung cancer 1996
14 1 p. 161-
1 p.
artikel
104 p53 and K-ras in radon-associated lung adenocarcinoma 1996
14 1 p. 150-
1 p.
artikel
105 Patterns of DNA methylation of the parathyroid hormone-related protein gene in human lung carcinoma 1996
14 1 p. 156-
1 p.
artikel
106 Phase II study of all-trans-retinoic acid and α-interferon in patients with advanced non-small cell lung cancer 1996
14 1 p. 167-
1 p.
artikel
107 Phase II trial and cost analysis of fazarabine in advanced nonsmall cell carcinoma of the lung: A southwest oncology group study 1996
14 1 p. 169-
1 p.
artikel
108 Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer 1996
14 1 p. 171-
1 p.
artikel
109 Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report Shepherd, Frances A.
1996
14 1 p. 135-144
10 p.
artikel
110 p53 immunostaining in combined type small cell lung cancer. Brief report 1996
14 1 p. 155-
1 p.
artikel
111 Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988–1992 Debevec, Miha
1996
14 1 p. 99-107
9 p.
artikel
112 P53 polymorphisms and haplotypes in lung cancer 1996
14 1 p. 150-
1 p.
artikel
113 Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer 1996
14 1 p. 176-177
2 p.
artikel
114 Pre-operative chemotherapy for stage IIIa (N2)non-small cell lung cancer 1996
14 1 p. 176-
1 p.
artikel
115 Prognostic analysis of lung cancer patients with brain metastasis and evaluation of long term survivors 1996
14 1 p. 159-
1 p.
artikel
116 Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: An analysis in each pathologic stage 1996
14 1 p. 160-
1 p.
artikel
117 Prognostic significance of CD44 expression in adenocarcinoma of the lung 1996
14 1 p. 161-
1 p.
artikel
118 Proliferation markers MIB-1 and PCNA in pulmonary neuroendocrine tumors 1996
14 1 p. 163-
1 p.
artikel
119 Protective effect of jiaogulan on cellular immunity of the patients with primary lung cancer treated by radiotherapy plus chemotherapy 1996
14 1 p. 156-
1 p.
artikel
120 Pulmonary function 3–12 months after pneumonectomy, lobectomy or bilobectomy for lung cancer 1996
14 1 p. 165-
1 p.
artikel
121 Pulmonary scar carcinoma: Report of three cases and review of the literature 1996
14 1 p. 157-
1 p.
artikel
122 Radiation studies on B cell differentiation marker CD24 SCLC Cluster-4 antigen expressing and non-expressing lung cancer cell lines and mouse fibroblasts 1996
14 1 p. 174-
1 p.
artikel
123 Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3 1996
14 1 p. 178-
1 p.
artikel
124 Radiotherapy for lung cancer: Comparison of results 628 patients treated with palliative and radical treatment 1996
14 1 p. 175-
1 p.
artikel
125 Radiotherapy of lung cancer 1996
14 1 p. 174-
1 p.
artikel
126 Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer 1996
14 1 p. 164-
1 p.
artikel
127 Results of various modalities of non-surgical treatment of small cell carcinoma of the lungs 1996
14 1 p. 176-
1 p.
artikel
128 Risk analysis and long-term survival in patients undergoing extended resection of locally advanced lung cancer 1996
14 1 p. 166-
1 p.
artikel
129 Risk of lung cancer in pre- and post-menopausal women with ano-genital malignancies 1996
14 1 p. 151-
1 p.
artikel
130 Role of genetic factors in bronchial cancer. Based upon a case of anaplastic lung carcinoma in identical twins 1996
14 1 p. 150-
1 p.
artikel
131 Simultaneous use of the PCR-SSCP method and immuno-histochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer 1996
14 1 p. 156-
1 p.
artikel
132 Small cell lung cancer with and without superior vena cava syndrome: A multivariate analysis of prognostic factors in 408 cases 1996
14 1 p. 160-
1 p.
artikel
133 Somatic genetic changes in lung cancer and precancerous lesions 1996
14 1 p. 150-
1 p.
artikel
134 Squamous cell carcinoma of the lung with high CT number, but without calcification 1996
14 1 p. 163-
1 p.
artikel
135 Stage I nonsmall cell lung cancer: A multivariate analysis of treatment methods and patterns of recurrence 1996
14 1 p. 165-
1 p.
artikel
136 Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer 1996
14 1 p. 173-174
2 p.
artikel
137 Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: Detection by reverse transcriptase-polymerase chain reaction 1996
14 1 p. 155-
1 p.
artikel
138 Surgical treatment of lung cancer in patients with human immunodeficiency virus 1996
14 1 p. 166-
1 p.
artikel
139 Surgical treatment of non-small cell lung carcinoma in TNM stage IIIA 1996
14 1 p. 166-
1 p.
artikel
140 Survival in early-stage non-small cell lung cancer 1996
14 1 p. 160-
1 p.
artikel
141 Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer 1996
14 1 p. 163-
1 p.
artikel
142 The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy 1996
14 1 p. 174-175
2 p.
artikel
143 The close relationship between growth factors and the nucleolar organizer regions in adenocarcinoma of the lung 1996
14 1 p. 156-
1 p.
artikel
144 The early detection of pleural dissemination of lung cancer by thin-slice computed tomography 1996
14 1 p. 159-
1 p.
artikel
145 The economics of lung cancer Boyer, Michael
1996
14 1 p. 13-17
5 p.
artikel
146 The economics of lung cancer management in Canada Evans, W.K.
1996
14 1 p. 19-29
11 p.
artikel
147 The effectiveness of transthoracic biopsy in diagnosis and treatment of neoplasms of chest organs 1996
14 1 p. 161-
1 p.
artikel
148 The influence of radiation and nonradiation factors on the lung cancer incidence among the workers of the nuclear enterprise Mayak 1996
14 1 p. 149-
1 p.
artikel
149 The peculiarities of metastatic spreading of lung cancer in cases of hereditary-related incidence 1996
14 1 p. 161-
1 p.
artikel
150 The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy 1996
14 1 p. 157-158
2 p.
artikel
151 The surgery of lung cancer 1996
14 1 p. 166-
1 p.
artikel
152 The treatment of patients with recurrent brain metastases: A retrospective analysis of 109 patients with nonsmall cell lung cancer 1996
14 1 p. 162-
1 p.
artikel
153 The tumour marker ‘Neuron-Specific enolase’ as prognosis indicator in small-cell bronchial carcinoma 1996
14 1 p. 160-
1 p.
artikel
154 The usefulness of the nebulization chemotherapy in the treatment of lung cancer 1996
14 1 p. 172-
1 p.
artikel
155 Urinary cotinine and lung cancer risk in a female cohort 1996
14 1 p. 151-
1 p.
artikel
156 Urinary nicotine metabolite excretion and lung cancer risk in a female cohort 1996
14 1 p. 151-
1 p.
artikel
                             156 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland